Zentalis Pharmaceuticals, Inc. (ZNTL)
ZNTL Stock Price Chart
Explore Zentalis Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ZNTL price movements and trends.
ZNTL Company Profile
Discover essential business fundamentals and corporate details for Zentalis Pharmaceuticals, Inc. (ZNTL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Apr 2020
Employees
106.00
Website
https://www.zentalis.comCEO
Julia Marie Eastland
Description
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
ZNTL Financial Timeline
Browse a chronological timeline of Zentalis Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.45.
Earnings released on 12 May 2026
EPS came in at -$0.50 falling short of the estimated -$0.49 by -2.04%.
Earnings released on 26 Mar 2026
EPS came in at -$0.49 falling short of the estimated -$0.41 by -19.51%.
Earnings released on 10 Nov 2025
EPS came in at -$0.37 surpassing the estimated -$0.49 by +24.49%.
Earnings released on 6 Aug 2025
EPS came in at -$0.37 surpassing the estimated -$0.56 by +33.93%.
Earnings released on 14 May 2025
EPS came in at -$0.67 matching the estimated -$0.67.
Earnings released on 26 Mar 2025
EPS came in at -$0.66 surpassing the estimated -$0.75 by +12.00%, while revenue for the quarter reached $26.87m .
Earnings released on 12 Nov 2024
EPS came in at -$0.56 surpassing the estimated -$0.92 by +39.13%.
Earnings released on 9 Aug 2024
EPS came in at -$1.24 falling short of the estimated -$0.83 by -49.40%.
Earnings released on 7 May 2024
EPS came in at $0.14 surpassing the estimated -$0.77 by +118.18%, while revenue for the quarter reached $40.56m , beating expectations by +209.15%.
Earnings released on 27 Feb 2024
EPS came in at -$0.83 surpassing the estimated -$0.92 by +9.78%, while revenue for the quarter reached $2.10m .
Earnings released on 6 Nov 2023
EPS came in at -$0.79 surpassing the estimated -$1.01 by +21.78%.
Earnings released on 9 Aug 2023
EPS came in at -$1.85 falling short of the estimated -$1.06 by -74.53%.
Earnings released on 10 May 2023
EPS came in at -$1.07 falling short of the estimated -$0.96 by -11.46%.
Earnings released on 1 Mar 2023
EPS came in at -$0.92 surpassing the estimated -$1.09 by +15.60%.
Earnings released on 9 Nov 2022
EPS came in at -$0.96 surpassing the estimated -$1.15 by +16.52%.
Earnings released on 9 Aug 2022
EPS came in at -$1.34 falling short of the estimated -$1.21 by -10.74%.
Earnings released on 5 May 2022
EPS came in at -$1.31 falling short of the estimated -$1.20 by -9.17%.
Earnings released on 24 Feb 2022
EPS came in at -$1.11 surpassing the estimated -$1.34 by +17.16%.
Earnings released on 10 Nov 2021
EPS came in at -$0.09 surpassing the estimated -$1.31 by +93.13%.
Earnings released on 12 Aug 2021
EPS came in at -$1.34 falling short of the estimated -$1.14 by -17.54%.
ZNTL Stock Performance
Access detailed ZNTL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
